Thermo Fisher Scientific (TMO) Other Non-Current Liabilities (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Other Non-Current Liabilities for 18 consecutive years, with $4.4 billion the latest figure, recorded in Q1 2026.

• Other Non-Current Liabilities for Q1 2026 came in at $4.4 billion, up 11.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.4 billion (up 11.33% YoY), and the FY2025 annual result was $4.3 billion, up 7.12% from the prior year.
• Other Non-Current Liabilities was $4.4 billion for Q1 2026 at Thermo Fisher Scientific, up from $4.3 billion in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $4.7 billion in Q2 2022 and troughed at $4.0 billion in Q1 2025.
• Average Other Non-Current Liabilities over 5 years is $4.3 billion, with a median of $4.3 billion recorded in 2023.
• Year-over-year, Other Non-Current Liabilities jumped 39.14% in 2022 and decreased 14.07% in 2024.
• Over 5 years, Other Non-Current Liabilities stood at $4.2 billion in 2022, then rose by 9.53% to $4.6 billion in 2023, then declined by 14.07% to $4.0 billion in 2024, then advanced by 7.12% to $4.3 billion in 2025, then climbed by 3.46% to $4.4 billion in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $4.4 billion in Q1 2026, $4.3 billion in Q4 2025, and $4.3 billion in Q3 2025.